SAN FRANCISCO–(BUSINESS WIRE)–#glp1–Telehealth company Henry Meds, known for its commitment to patient-centric care, announced the launch of Compounded Oral Dissolving Tirzepatide Tablets. Henry Meds is among the first to introduce this groundbreaking oral format of tirzepatide to the market.
With the rising demand for effective weight management solutions, eligible patients can now access Compounded Oral Dissolving Tirzepatide Tablets through Henry’s convenient online medical clinic. Patients can determine whether they qualify for treatment by completing a simple form.
Eligible patients enjoy:
No Injection, Same Active Ingredient as Mounjaro® and Zepbound®**: This breakthrough dissolving tablet makes it easy for patients who prefer to take their medication orally. Henry Meds exclusively works with licensed compounding pharmacies that source active pharmaceutical ingredients from FDA-registered sources.
Everything Included: Patients meet licensed providers online to get prescribed at a time and place that works for them, eliminating the hassle of in-person visits. The cost includes the prescription, provider visits, medication, patient portal access, and ongoing support–with no added membership cost or hidden fees.
No Insurance Needed: Patients get all-inclusive care without dependence on insurance coverage.
Affordable Care from Trusted Clinicians: Patients get cost-effective medical weight loss options. Henry Meds’ clinicians provide personalized support throughout the treatment journey, adapting medication dosage to evolving patient needs.
Tirzepatide has demonstrated remarkable efficacy in supporting weight loss. By enhancing insulin production, reducing glucagon secretion, and modulating appetite-regulating brain areas, Tirzepatide offers comprehensive support for individuals striving for healthier lifestyles.
Henry Meds is a leading telehealth platform dedicated to revolutionizing healthcare delivery. Through innovation and a commitment to patient-centric care, Henry Meds empowers individuals to access quality healthcare solutions affordably and conveniently, continuing its mission to make healthcare more accessible for everyone.
*Note: Mounjaro® and Zepbound® are registered trademarks of their respective owners and are mentioned for informational purposes only. Henry Meds™ is not affiliated with or endorsed by the owners of these trademarks. The compounded medications accessible through the Henry Meds platform are only available with a prescription from a licensed healthcare provider after a telehealth appointment; these compounded medications have not undergone pre-market review by the FDA and are not FDA-approved.
Contacts
